19
Think(ing) Kidneys Raising the profile of AKI in England Dr Richard Fluck [email protected], Chair, Think Kidneys

AKI Manchester 2017

Embed Size (px)

Citation preview

Page 1: AKI Manchester 2017

Think(ing) KidneysRaising the profile of AKI in EnglandDr Richard [email protected],Chair, Think Kidneys

Page 2: AKI Manchester 2017

01/05/2023 | 2

An ‘intermediate’ health stateAssociated with other serious illness

Important marker of illness severity

“Force multiplier” for poor outcomes

Potential to improve care

Reduce avoidable harm - death and morbidity

Reduce cost

Acute Kidney Injury National Programme | Richard Fluck

Page 3: AKI Manchester 2017

01/05/2023Acute Kidney Injury National Programme | Richard Fluck | 3

‘Think Kidneys’ AKI Programme

Who is at risk?

When do people sustain AKI?

How should patients with AKI be

managed?

What do people need to know?

Page 4: AKI Manchester 2017

01/05/2023KDIGO Clinical Practice Guideline for Acute Kidney InjuryKidney International Supplement 2012; 2(1): 1-138

How is AKI defined?

Acute Kidney Injury National Programme | Richard Fluck | 4

Page 5: AKI Manchester 2017

01/05/2023

National Algorithm

Based in LIMS

Compares serial creatinine measures

It provides a warning test score to be

used in the context of clinical

judgement

| 5Acute Kidney Injury National Programme | Richard Fluck

Page 6: AKI Manchester 2017

01/05/2023Acute Kidney Injury National Programme | Richard Fluck | 7

Improving diagnosis: using changes in serum creatinine

Laboratory definition and standardisation

Page 7: AKI Manchester 2017

01/05/2023 | 8

Detect Alert

Lets talk about ‘alerts’

Respond

Acute Kidney Injury National Programme | Richard Fluck

AKI Warning stage

Page 8: AKI Manchester 2017

01/05/2023

Developing and disseminating resources

Acute Kidney Injury National Programme | Richard Fluck | 9

Page 9: AKI Manchester 2017

01/05/2023Acute Kidney Injury National Programme | Richard Fluck | 10

Page 10: AKI Manchester 2017

01/05/2023

Key pointsFew drugs are ‘nephrotoxic’ – avoid use of word

Most drugs are ‘situational’ in cases of AKI

1. Causative2. Adjuncts3. Altered side effect profile

Role in reducing risk of AKISick day guidance position

statementhttp://bit.ly/22sGdbs

Acute Kidney Injury National Programme | Richard Fluck | 15

Medicines management http://bit.ly/1TNSGTD

Page 11: AKI Manchester 2017

01/05/2023Acute Kidney Injury National Programme | Richard Fluck | 17

The community and care homes http://bit.ly/1TJG00K

Page 12: AKI Manchester 2017

01/05/2023

Public awareness campaign http://bit.ly/1OViw3K

Acute Kidney Injury National Programme | Richard Fluck | 18

Page 13: AKI Manchester 2017

‘AKI warning stage’

Patient management

system

Alert Response

Local systems

MessageMaster patient index

Other data systems

AKI Registry

RegionalNational Research

QI

System Measurement

19

Page 14: AKI Manchester 2017

01/05/2023Acute Kidney Injury National Programme | Richard Fluck

76 laboratories now reporting

861,497 AKI warning levels in 272,402 patients reported (July 2016)

99.5% NHS number completeness

| 20

Measurement http://bit.ly/1TJG00K

0

10

20

30

40

50

60

70

80

90

Stage 1 Stage 2 Stage 3

Perc

enta

ge

AKI stage

AdultsPaeds

Page 15: AKI Manchester 2017

01/05/2023

Why? High readmission ratesPrimary care knowledgeFuture riskMedicines management

Acute Kidney Injury National Programme | Richard Fluck | 21

Commissioning: national CQUIN

Page 16: AKI Manchester 2017

CQUIN Elements: discharge summary items on AKIStage of AKI; (a key aspect of AKI diagnosis)Evidence of medicines review having been undertaken (a key aspect of AKI treatment) Type of blood tests required on discharge for monitoring (a key aspect of post discharge care)Frequency of blood tests required on discharge for monitoring (a key aspect of post discharge care)Data from > 29000 case notes in 2015/16

Page 17: AKI Manchester 2017

01/05/2023

The brand and legacyDataToolsExemplarsLeadership

System LinksNHS ImprovementNHS England

NICESustainability

UK Renal Registry and funding Acute Kidney Injury National Programme | Richard Fluck | 23

Going forward – sustainability and programme future

Page 18: AKI Manchester 2017

01/05/2023

www.thinkkidneys.nhs.uk A summary

Think Kidneys

Has delivered system leversProviding a framework for actionRaised the profileIt is supportive of other change agents

Acute Kidney Injury National Programme | Richard Fluck | 24

Page 19: AKI Manchester 2017

01/05/2023

Karen ThomasThink Kidneys Programme ManagerUK Renal [email protected]

Annie TaylorCommunications Consultant to the Acute Kidney Injury National [email protected]

The UK Renal Registry team, chairs, co-chairs and teams of all the workstreams in ‘Think Kidneys’

Joan RussellHead of Patient SafetyNHS [email protected]

Ron CullenDirectorUK Renal [email protected]

www.linkedin.com/company/think-kidneys

www.twitter.com/ThinkKidneys

www.facebook.com/thinkkidneys

www.youtube.com/user/thinkkidneys

www.slideshare.net/ThinkKidneys

www.thinkkidneys.nhs.uk

Acknowledgements

Acute Kidney Injury National Programme | Richard Fluck | 25